SEC Form D · filed February 9, 2017
Tarveda Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Dennis C. Ausiello · Watertown, MADirectorRichard C. Wooster · Watertown, MAExecLeila C. Alland · Watertown, MAExecAndrew J. Fromkin · Watertown, MAExec · DirectorAymeric S. Sallin · Watertown, MADirectorOmid C. Farokhzad · Watertown, MADirectorNilesh C. Kumar · Watertown, MADirectorJames J. Barrett · Watertown, MADirectorFrank C. Torti · Watertown, MADirectorGuido S. Magni · Watertown, MADirectorMichael D. Weinberg · Dallas, TXDirectorNancy P. Carlson · Dallas, TXDirectorJustin Jory · San Francisco, CAExecLee Ainslie Iii · Dallas, TXDirectorMark Phelps · PHOENIX, AZDirectorDavid Hirschfeld · PHOENIX, AZExecTheodore Haig · PHOENIX, AZDirectorAndrew Saltoun · San Francisco, CAExec · DirectorRobert S. Langer, Jr · Watertown, MADirectorBarry Fernando · PHOENIX, AZExecJohn S. Koudounis · Naperville, ILExec · DirectorThomas E. Herman · Naperville, ILDirectorFreshun D. Flowers · Tuscaloosa, ALDirectorBrian A. Meyer · New York, NYDirectorThomas Shandell · Greenwich, CTDirectorJeffrey Bisberg · Austin, TXExecGregory S. Oberholtzer · Chicago, ILDirectorElizabeth A. Dickman · Amston, CTDirectorRobert S. Langer, Jr · Watertown, MADirectorGuido S. Magni · Watertown, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗